Awardee OrganizationRESEARCH INST OF FOX CHASE CAN CTR
Description
Abstract Text
DESCRIPTION: (Adapted from Applicant's Abstract) The porphobilinogen synthases
(PBGS's) are ancient proteins, essential to nearly all cellular organisms. They
catalyze the first common step in tetrapyrrole biosynthesis (i.e., porphyrin,
chlorophyll, vitamin B12, etc.), which is the condensation of two molecules of
5-aminolevulinic acid to form porphobilinogen. To date, only one reaction
intermediate is known for this complex reaction. All PBGS's are metalloenzymes
and metal ion usage has suffered a unique phylogenetic switch between Zn(II)
and Mg(II). Human PBGS is the primary target for lead poisoning and the less
frequent of two alleles is reported to predispose humans toward this
environmental disease. The proposed studies address various aspects of the
PBGS's. The first specific aim uses a novel "designer gene" approach to produce
and purify 100 mg quantities of human and pea PBGS because human PBGS uses
Zn(II) and pea PBGS uses Mg(II). The second aim is to characterize the PBGS
derived from two common human alleles and determine the molecular basis for
their apparent Pb(II)-related differences. This aim includes a thorough kinetic
and biochemical characterization of the human proteins, including 13C NMR and
collaborative EXAFS and Raman spectroscopies and X-ray crystallography. The
Raman data are complementary to the 13C NMR data on active site ligands. The
third aim uses mutagenesis in conjunction with kinetics, metal and substrate
binding studies, and magnetic resonance techniques, plus collaborative
techniques to probe structure/function relationships in PBGS. The mutations
will allow us to characterize the yet unknown intermediates in the
PBGS-catalyzed reaction. Some mutations probe individual functions of the two
active site Zn(II) of human PBGS and others probe the structural basis for
half-sites reactivity in these homo-octameric proteins. The fourth aim focuses
on the intriguing phylogenetic switch between the catalytically essential
Zn(II) vs. Mg(II). Studies are directed at pea PBGS and also probe an
allosteric Mg(II), absent in mammalian PBGS but present in plant and many
microbial PBGS. The sum of the proposed studies is expected to yield new and
important information on the mechanism of lead poisoning, on the intermediate
in the PBGS catalyzed reaction, on the possible roles of both Zn(II) and Mg(II)
in enzyme catalysis, on the structural basis for half sites reactivity, and on
the phylogenetic differences between PBGSs. Because PBGS is an essential enzyme
with distinct variations between species, we envision that a thorough
understanding of the phylogenetic differences will form the basis for the
rational design of a new class of organism-specific drugs.
National Institute of Environmental Health Sciences
CFDA Code
113
DUNS Number
064367329
UEI
FF1XVJMDYVR1
Project Start Date
01-April-1991
Project End Date
30-June-2003
Budget Start Date
01-July-2000
Budget End Date
30-June-2001
Project Funding Information for 2000
Total Funding
$334,166
Direct Costs
$199,131
Indirect Costs
$135,035
Year
Funding IC
FY Total Cost by IC
2000
National Institute of Environmental Health Sciences
$334,166
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01ES003654-17
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01ES003654-17
Patents
No Patents information available for 5R01ES003654-17
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01ES003654-17
Clinical Studies
No Clinical Studies information available for 5R01ES003654-17
News and More
Related News Releases
No news release information available for 5R01ES003654-17
History
No Historical information available for 5R01ES003654-17
Similar Projects
No Similar Projects information available for 5R01ES003654-17